Cite
[Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload].
MLA
Roujouleh, H., et al. “[Magnesium Hydroxide Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients with an Aluminum Overload].” Nephrologie, vol. 8, no. 2, 1987, pp. 45–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3614505&authtype=sso&custid=ns315887.
APA
Roujouleh, H., Lavaud, S., Toupance, O., Melin, J. P., & Chanard, J. (1987). [Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload]. Nephrologie, 8(2), 45–50.
Chicago
Roujouleh, H, S Lavaud, O Toupance, J P Melin, and J Chanard. 1987. “[Magnesium Hydroxide Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients with an Aluminum Overload].” Nephrologie 8 (2): 45–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3614505&authtype=sso&custid=ns315887.